Recently, Ibrahim et al. reported that exposing breast cancer cells to IGF-1 may cause a shift from IGF-1 receptor substrate (IRS)-1 phosphorylation to IRS-2 phosphorylation, leading to activated cell migration [23]. Here, IGF1 is linked to breast cancer.